Acute Cardiogenic Pulmonary Edema Management
Initial Treatment
- In acute cardiogenic pulmonary edema, an initial dose of 20-80 mg IV furosemide is recommended, as supported by the American Society of Nephrology 1
Dosage and Administration
- High doses of furosemide (>6 mg/kg/day) should not be given for periods longer than 1 week, and IV furosemide should be administered over 5-30 minutes to avoid hearing loss, as recommended by the American Society of Nephrology 2
- Furosemide must be discontinued in the case of anuria, as stated by the American Society of Nephrology 2
- The maximum dose of furosemide is 160 mg/day, often used in combination with spironolactone in a 40:100 mg ratio, according to the Clinical and Molecular Hepatology and Journal of Hepatology guidelines, with moderate evidence from the American Heart Association 3, 4
Special Populations
- Elderly patients are susceptible to dehydration due to age-related changes in thirst perception and renal function, making them more vulnerable to acute kidney injury (AKI) when taking certain medications, such as ramipril and furosemide, as recommended by the European Heart Journal 5, 6
- The American Geriatrics Society recommends starting at lower doses and titrating slowly in elderly patients, with more frequent monitoring of electrolytes and renal function, due to higher risk of dehydration and orthostatic hypotension, with strong evidence from the American College of Cardiology 7
- The American Academy of Pediatrics recommends an initial dose of 0.5-2.0 mg/kg of furosemide for acute, rapid diuresis, and a maximum dose of chlorthalidone is 50 mg/day, with moderate evidence from the American Heart Association 8
Monitoring and Adverse Effects
- Regular clinical observation, laboratory monitoring of electrolytes, renal function tests, and assessment for adverse effects are recommended when using high doses of furosemide (>80 mg/day) for prolonged periods, although no specific citation is provided for this recommendation, the Journal of Hepatology recommends careful monitoring, with a strength of evidence supported by the American Society of Nephrology 4, 9
- Parameters to monitor include diuresis and fluid balance, daily weight, serum electrolytes (especially sodium, potassium, magnesium), and renal function (creatinine, urea), as stated by the European Heart Journal and the American Heart Association 9, 7
- Potential adverse effects with high doses of furosemide include ototoxicity, electrolyte imbalances, dehydration, and gout, although no specific citation is provided for this recommendation, the Journal of Hepatology recommends monitoring for adverse effects, with moderate evidence from the American College of Cardiology 4, 7
Concomitant Medications and Interactions
- Furosemide should be used with caution in patients on levothyroxine, as they can induce hypovolemia and promote thrombosis, according to the American College of Cardiology guidelines, with strong evidence from the American Heart Association 2
- Certain medications, such as NSAIDs, aminoglycosides, and ACE inhibitors or ARB-II, may interact with furosemide, although no specific guideline society recommendations are provided for concomitant medications, with moderate evidence from the American Society of Nephrology 7, 10
Dosing Guidelines
| Population | Initial Dose | Maximum Dose |
|---|---|---|
| Adults with mild to moderate renal insufficiency | 40 mg IV | 160 mg/day |
| Adults with severe renal insufficiency | 40-80 mg IV | individualized |
| Elderly patients | lower doses, titrated slowly | individualized |
| Children with acute, rapid diuresis | 0.5-2.0 mg/kg | 50 mg/day (chlorthalidone) |
| Children with cirrhotic ascites | 0.5 mg/kg/dose twice daily | individualized |
Prevention of Acute Kidney Injury (AKI)
- The combination of an ACE inhibitor (e.g., ramipril) and a loop diuretic (e.g., furosemide) can cause AKI in frail elderly patients experiencing vomiting, due to volume depletion and hemodynamic effects, with a strength of evidence supported by the American Geriatrics Society 6
- Educating patients about the importance of maintaining adequate hydration and providing clear instructions on when to hold medications during acute illness can help prevent AKI in patients taking ramipril and furosemide, as stated by the American College of Cardiology 5
- Assessing acid-base status and considering urine microscopy to evaluate for tubular injury are important steps in diagnosing and managing AKI in patients taking ramipril and furosemide, as recommended by the American Society of Nephrology 6
- Monitoring renal function, electrolytes, and vital signs is crucial in patients at risk of AKI, especially when taking medications that can affect kidney function, such as ACE inhibitors and loop diuretics, with high-level evidence from the American Heart Association 6